The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The goal of this randomized clinical trial is to investigate whether pressurized intraperitoneal chemotherapy (PIPAC), delivered immediately after minimally invasive D2 gastrectomy and repeated 6-8 weeks later, improves 12-month peritoneal disease-free survival in patients with high-risk gastric adenocarcinoma when compared to standard treatment.
Epistemonikos ID: 8e50f80736d681fe5f52e1c6aef7d3cdd141b81c
First added on: May 15, 2024